Advertisement

Picture EBD Group World of Partnering Opportunities 650x100px

News > Benelux countries

Please find below news from the Benelux countries (Belgium, Luxembourg and The Netherlands) as well as about organisations from these countries.

Total search results: 1101 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
ProteoNic Biosciences B.V.. (3/13/23). "Press Release: ProteoNic Announces Partnership with Ginkgo Bioworks and Joins the Ginkgo Technology Network". 2024-03-13
Precirix N.V.. (2/29/24). "Press Release: Tom Plitz Commences Role as Chief Executive Officer of Precirix". Brussels. 2024-02-29
Centogene N.V.. (2/28/24). "Press Release: Centogene Explores Strategic Alternatives". Cambridge, MA, Rostock & Berlin. 2024-02-28
Centogene N.V.. (2/28/24). "Press Release: Centogene Announces Receipt of Nasdaq Notice of Delisting and Intention to Request a Hearing". Cambridge, MA, Rostock & Berlin. 2024-02-28
Royal Philips. (28/2/24). "Press Release: Charlotte Hanneman to Succeed Abhijit Bhattacharya as Philips’ Chief Financial Officer (CFO)". Amsterdam. 2024-02-28
Luxembourg Institute of Health (LIH). (2/27/24). "Press Release: Strategic Partnership Forges Innovation in Luxembourg HealthTech. Luxembourg Institute of Health and Catalpa Ventures Join Forces". 2024-02-27
InflaRx N.V.. (2/22/24). "Press Release: InflaRx Appoints Jan Medina as Head of Investor Relations". Jena. 2024-02-22
Candriam. (2/13/24). "Press Release: Candriam Strengthens Thematic Investing Expertise with New Appointments and Announces Leadership Transition". London. 2024-02-13
NLC Ventures Netherlands B.V.. (2/2/24). "Press Release: NLC Health Ventures and BioScience Valuation (BSV) Announce Strategic Collaboration". Amsterdam. 2024-02-02
Forbion Capital Partners. (1/9/24). "Press Release: Forbion Portfolio Company Aiolos Bio, Inc. (Aiolos) to Be Acquired by GSK for up to $1.4 Billion". 2024-01-09
Calypso Biotech B.V.. (1/8/24). "Press Release: Calypso Enters into Agreement to Be Acquired by Novartis". Amsterdam. 2024-01-08
Qiagen N.V.. (1/4/24). "Press Release: Qiagen to Accelerate Investments into Qiagen Digital Insights Bioinformatics Business". Venlo. 2024-01-04
Qiagen N.V.. (1/3/24). "Press Release: Qiagen Expands Business in Middle East with New Regional Headquarters and Major Projects". Venlo, Muscat & Ryadh. 2024-01-03
Ion Beam Applications S.A. (IBA). (12/5/23). "Press Release: IBA Signs Research Collaboration Agreement with the University of Kansas Medical Center on FLASH Technology". Louvain-la-Neuve. 2023-12-05
ECBF Management GmbH. (11/21/23). "Press Release: 17 Million Euros for Sustainable Agriculture. ECBF Leads RED Horticulture Series A Financing Round, Together with Demeter IM and Unigrains". Luxembourg. 2023-11-21
Bioxodes S.A.. (11/21/23). "Press Release: Bioxodes Closes €12 Million in Series A Funding Round". Gosselies. 2023-11-21
Gilde Healthcare Partners. (11/15/23). "Press Release: Gilde Healthcare Closes New Venture&Growth Fund at €740 Million Hard Cap". Utrecht. 2023-11-15
SwiftPharma B.V.. (11/13/23). "Press Release: SwiftPharma and PlantForm Corporation Target Blockbuster Cancer Drug with New Contract Manufacturing Agreement for Plant-made Biosimilars". Ghent & Toronto, ON. 2023-11-13
VectorY Therapeutics B.V.. (11/13/23). "Press Release: VectorY Raises €129 Million ($138 Million) Series A Financing to Advance Vectorized Antibody Programs in Neurodegenerative Diseases". Amsterdam. 2023-11-13
Kynexis B.V.. (11/7/23). "Press Release: Kynexis Launched to Advance Precision Therapeutics for Brain Diseases". Naarden. 2023-11-07
Immatics N.V.. (10/24/23). "Press Release: Immatics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for ACTengine® IMA203 TCR-T Monotherapy". Houston, TX & Tübingen. 2023-10-24
BioLizard N.V.. (10/11/23). "Press Release: BioLizard Launches New AI-empowered “BioVerse” Platform to Facilitate Data-driven R&D for Global Life Sciences Community". Ghent. 2023-10-11
Agomab Therapeutics N.V.. (10/10/23). "Press Release: Agomab Raises $100 Million Series C to Advance Fibrosis-focused Pipeline". Ghent. 2023-10-10
Agomab Therapeutics N.V.. (10/5/23). "Press Release: Agomab Receives FDA Fast Track Designation for AGMB-129 in Fibrostenosing Crohn’s Disease and Starts STENOVA Phase 2a Clinical Trial". Ghent. 2023-10-05
Qiagen N.V.. (9/25/23). "Press Release: Qiagen Enhances QIAwave Portfolio with New Eco-friendlier Nucleic Acid Extraction Kits". Venlo. 2023-09-25
ProteoNic B.V.. (9/19/23). "Press Release: NecstGen and ProteoNic Report Development of Improved Viral Vectors through the Application of Premium 2G UNic Technology". Leiden. 2023-09-19
Galapagos N.V.. (9/19/23). "Press Release: Galapagos Appoints Simon Sturge to Its Board of Directors". Mechelen. 2023-09-19
Aboleris Pharma. (9/18/23). "Press Release: Aboleris Pharma Announces €27 Million in Series A Financing to Advance its Novel Treatment Paradigm for Autoimmune and Inflammatory Diseases". Gosselies. 2023-09-18
Immatics N.V.. (9/11/23). "Press Release: Moderna and Immatics Announce Strategic Multi-Platform Collaboration to Develop Innovative Oncology Therapeutics". Cambridge, MA & Tübingen. 2023-09-11
ECBF Management GmbH. (9/4/23). "Press Release: 23 Million Euros for Sustainable Packaging Materials. ECBF Leads Paptic Financing Round". Luxembourg. 2023-09-04
Qiagen N.V.. (8/8/23). "Press Release: Qiagen Delivers Ahead of Outlook for Q2 2023 with 9% CER Sales Growth in Non-COVID Products and Updates 2023 Full-year Outlook". Venlo. 2023-08-08
Qiagen N.V.. (8/7/23). "Press Release: Qiagen Receives FDA Approval for Companion Diagnostic to Blueprint Medicines’ Ayvakit (avapritinib) in Gastrointestinal Stromal Tumors". Venlo & Germantown, MD. 2023-08-07
Qiagen N.V.. (7/26/23). "Press Release: Bio-Rad and Qiagen Announce Patent Settlement and Cross-licensing Agreement". Venlo. 2023-07-26
Immatics N.V.. (7/24/23). "Press Release: Immatics Announces $35 Million Equity Investment from Bristol Myers Squibb". Tübingen & Houston, TX. 2023-07-24
BioGeneration Ventures B.V.. (7/19/23). "Press Release: Dr. Markus Kalousek and Dr. Andrew Lightfoot Join BGV as Venture Partners". Amsterdam. 2023-07-19
HUB Organoids. (7/18/23). "Press Release: HUB Organoids Announces New Corporate Strategy and Completes Transition from Foundation to Private Company". Utrecht. 2023-07-18
Argenx SE. (7/18/23). "Press Release: Argenx Raises $1.1 Billion in Gross Proceeds in a Global Offering". Amsterdam. 2023-07-18
Argenx SE. (7/17/23). "Press Release: Argenx Announces Launch of Proposed Global Offering". Amsterdam. 2023-07-17
Argenx SE. (7/17/23). "Press Release: Argenx Reports Positive Topline Data from ADHERE Study of Vyvgart Hytrulo in Patients with Chronic Inflammatory Demyelinating Polyneuropathy". Amsterdam. 2023-07-17
BioGeneration Ventures B.V.. (7/13/23). "Press Release: BioGeneration Ventures Closes BGV Fund V at €150 Million". Naarden. 2023-07-13
River BioMedics. (7/5/23). "Press Release: River BioMedics Secures €2M Seed Investment to Progress Its Cardiovascular Disease Pipeline". Enschede. 2023-07-05
Centogene N.V.. (6/27/23). "Press Release: Centogene and Lifera, a Biopharma Company Owned by the PIF, Enter Strategic Collaboration – Forming Saudi Arabian Joint Venture to Increase Access to Leading Data-Driven Multiomic Testing and Securing CENTOGENE 2023-06-27
NLC Ventures Netherlands B.V.. (6/26/23). "Press Release: NLC Announces It Has Completed the Initial Close of the NLC Health Impact Fund". 2023-06-26
Tagworks Pharmaceuticals B.V.. (6/22/23). "Press Release: Tagworks Pharmaceuticals Announces $65 Million in Series A Financing to Advance Click-to-Release Therapeutics". Nijmegen & Boston, MA. 2023-06-22
Qiagen N.V.. (6/15/23). "Press Release: Qiagen’s QuantiFERON-TB Gold Plus Shows Unique Clinical Value with CD8 Technology in New Meta-analysis of Tuberculosis Screening". Venlo. 2023-06-15
Galapagos N.V.. (6/15/23). "Press Release: Galapagos Appoints Thad Huston as Chief Financial Officer and Chief Operating Officer". Mechelen. 2023-06-15
Centogene N.V.. (6/14/23). "Press Release: Centogene Receives Nasdaq Notification Regarding Minimum Market Value of Publicly Held Shares Deficiency". Cambirdge, MA, Rostock & Berlin. 2023-06-14
Galapagos N.V.. (6/12/23). "Pressemitteilung: Galapagos Appoints Dr. Susanne Schaffert as Non-executive Independent Director to Its Board". Mechelen. 2023-06-12
Gilde Healthcare Partners. (6/9/23). "Press Release: Gilde Healthcare Strengthens Investor Relations and Fundraising Team with Besmire Ahmati". Utrecht. 2023-06-09
Newton Biocapital. (6/7/23). "Press Release: Santero Announces a €8 Million Series A Funding Round Led by Newton Biocapital to Develop Novel Antibiotics in the Fight against Antimicrobial Resistance". Brussels. 2023-06-07
Precirix N.V.. (6/6/23). "Press Release: CAM-H2 Production at Evergreen Marks the Expansion of Precirix’ Clinical Trial to the US". Brussels & Springfield, NJ. 2023-06-06
Mithra Pharmaceuticals S.A.. (5/29/23). "Press Release: Mithra Appoints Experienced Life Sciences Executive Christian Homsy as Chairman". Liège. 2023-05-29
VarmX B.V.. (5/25/23). "Press Release: VarmX Raises €30 Million Series B2 Financing for IND Approval and Preparations for Pivotal Trial". Leiden. 2023-05-25
QbD Group. (5/25/23). "Press Release: The QbD Group Acquires Turnstone Communications to Strengthen Its Specialist Science Communication and Business Development Services". 2023-05-25
QbD Group. (5/25/23). "Press Release: The QbD Group Acquires Michor Consulting to Enhance Its Regulatory Affairs Services across Europe". 2023-05-25
Council of European BioRegions (CEBR). (5/17/23). "Press Release: CEBR Appoints New President and Vice-President at Its Annual Meeting 2023". Stuttgart. 2023-05-17
Qiagen N.V.. (5/15/23). "Press Release: Qiagen Expands Enzyme Offering to Support Individual Life Science Research Labs Worldwide". Berlin. 2023-05-15
Dualyx N.V.. (5/15/23). "Press Release: Dualyx Raises €40 Million to Progress Treg Therapies for Autoimmune Diseases into the Clinic". Ghent. 2023-05-15
Uniqure N.V.. (5/15/23). "Press Release: Uniqure Announces Sale of Royalty Interest in Hemgenix for up to $400 Million". Lexington, MA & Amsterdam. 2023-05-15
Biocartis Group N.V.. (5/9/23). "Press Release: Biocartis and HiloProbe to Collaborate on Colorectal Cancer Test". Mechelen. 2023-05-09
Qiagen N.V.. (5/3/23). "Press Release: Qiagen Exceeds Outlook for Q1 2023 with 12% CER Sales Growth in Non-COVID Product Portfolio". Venlo. 2023-05-03
Anavo Therapeutics B.V.. (5/2/23). "Press Release: Anavo Therapeutics Extends Seed Round to EUR 28 Million to Advance Pipeline of Novel Phosphatase Modulators Toward the Clinic". Leiden & Heidelberg. 2023-05-02
Immatics N.V.. (5/2/23). "Press Release: Immatics Reports Interim Clinical Data from Ongoing Phase 1b Cohort A Monotherapy with ACTengine IMA203 TCR-T Targeting PRAME". Houston, TX & Tübingen. 2023-05-02
Immatics N.V.. (5/1/23). "Press Release: Immatics Announces First Bristol Myers Squibb Opt-in of TCR-T Candidate from Ongoing Multi-target Strategic Collaboration". Tübingen & Houston, TX. 2023-05-01
Biotalys N.V.. (4/24/23). "Press Release: Syngenta and Biotalys Enter into Strategic Partnership in Biologicals Innovation to Advance Solutions for Sustainable Agriculture". Basel & Ghent. 2023-04-24
Forbion Capital Partners. (4/19/23). "Press Release: Forbion Raises €1.35 Billion across Two Funds". Espoo. 2023-04-19
Gilde Healthcare Partners. (4/19/23). "Press Release: Gilde Healthcare Raises €600 Million to Invest in Healthcare innovation". Utrecht. 2023-04-19
InflaRx N.V.. (4/18/23). "Press Release: InflaRx Announces Closing of the Full Exercise of Greenshoe Option Increasing the Proceeds of the Recently Announced Public Offering of Ordinary Shares to US$46 million". Jena. 2023-04-18
Argenx SE. (4/17/23). "Press Release: Argenx and Genmab Enter Partnership to Advance Antibody Therapies in Immunology and Oncology". Amsterdam. 2023-04-17
InflaRx N.V.. (4/14/23). "Press Release: InflaRx Announces Closing of $40 Million Public Offering of Ordinary Shares". Jena. 2023-04-14
InflaRx N.V.. (4/11/23). "Press Release: InflaRx Announces Pricing of $40 Million Public Offering of Ordinary Shares". Jena. 2023-04-11
Biocartis Group N.V.. (4/11/23). "Press Release: Biocartis Appoints Roger Moody as New CEO". Mechelen. 2023-04-11
InflaRx N.V.. (4/11/23). "Press Release: InflaRx Announces Public Offering of Ordinary Shares". Jena. 2023-04-11
Mithra Pharmaceuticals S.A.. (4/4/23). "Press Release: Mithra Announces the Appointment of David H Solomon as Chief Executive Officer". Liège. 2023-04-04
InflaRx N.V.. (4/4/23). "Press Release: InflaRx Receives FDA Emergency Use Authorization for Gohibic (vilobelimab) for Treatment of Critically Ill COVID-19 Patients". Jena. 2023-04-04
Biocartis Group N.V.. (4/4/23). "Press Release: Biocartis and APIS Assay Technologies Sign Collaboration to Develop and Commercialise a Breast Cancer Subtyping Test on the Idylla Platform". Mechelen. 2023-04-04
Pan Cancer T B.V.. (4/3/23). "Press Release: Pan Cancer T Appoints Rachel Abbott to Succeed Katrien Reynders-Frederix as Chief Executive Officer". Baar. 2023-04-03
EQT AB. (3/29/23). "Press Release: EQT Life Sciences Closes Dementia Fund at the Hard Cap". 2023-03-29
Vitestro. (3/21/23). "Press Release: Vitestro Raises EUR 12 Million in Series A Financing Round to Bring the World's First Autonomous Blood Drawing Device to the European Market". Utrecht. 2023-03-21
VectorY Therapeutics B.V.. (3/20/23). "Press Release: VectorY Appoints Michael Wyzga as CFO and Adds Jean Franchi to Its Board of Directors". Amsterdam. 2023-03-20
i&i Biotech Fund. (3/15/23). "Press Release: i&i Biotech Fund Will Invest up to EUR 340 000 into Czech Startup Sophomer s.r.o.". Prague. 2023-03-15
UCB S.A.. (3/15/23). "Press Release: Aitia and UCB Announce Strategic Drug Discovery Collaboration in Huntington's Disease". Brussels & Somerville, MA. 2023-03-15
UCB S.A.. (3/9/23). "Press Release: Cancer Research UK Signs Multi-Project Collaboration with UCB to Advance Oncology Antibody Candidates". Brussels & London. 2023-03-09
UCB S.A.. (3/9/23). "Press Release: UCB’s Board of Directors Appoints Jonathan Peacock as New Chair". Brussels. 2023-03-09
Confo Therapeutics N.V.. (3/2/23). "Press Release: Confo Therapeutics Announces Global Licensing Agreement with Lilly for Peripheral Pain Candidate, CFTX-1554". Ghent. 2023-03-02
Paleo B.V.. (2/22/23). "Press Release: Paleo Raises €12M to Bring the Real Taste of Meat to Plant-based Foods". Brussels. 2023-02-22
Qiagen N.V.. (2/14/23). "Press Release: Qiagen’s Tuberculosis Blood Test QuantiFERON-TB Gold Plus Gains CE-marking Under New EU IVDR Framework". Venlo. 2023-02-14
Qiagen N.V.. (2/7/23). "Press Release: Qiagen Exceeds Outlook for Fourth Quarter and Full-year 2022 with 14% CER Sales Growth in FY 2022 from Non-COVID Product Groups". Venlo. 2023-02-07
Novalis Biotech. (2/6/23). "Press Release: Novalis Biotech Invests in Rarity Bioscience’s Ultra Sensitive Genomics Technology". Uppsala. 2023-02-06
Exothera S.A.. (2/1/23). "Press Release: Exothera Announces the Appointment of Darren Leva as Chief Business Officer". Jumet. 2023-02-01
Uniqure N.V.. (1/31/23). "Press Release: uniQure and Apic Bio Enter into Global Licensing Agreement for APB-102, a Clinical Stage Gene Therapy for Patients with ALS Caused by Mutations in SOD1". Lexington, MA, Amsterdam & Cambridge, MA. 2023-01-31
VarmX B.V.. (1/31/23). "Press Release: VarmX Appoints Paul Roos as Chief Financial Officer". Leiden. 2023-01-31
Rewind Therapeutics. (1/25/23). "Press Release: Rewind Therapeutics Raises Additional Funding and Adds Sunstone Life Science Ventures A/S as New Investor". Leuven. 2023-01-25
TME Pharma N.V.. (1/23/23). "Press Release: TME Pharma Provides Clinical Update on the GLORIA Expansion Arm Testing NOX-A12 in Combination with Radiotherapy and Bevacizumab in Patients with Glioblastoma". Berlin. 2023-01-23
DeuterOncology N.V.. (1/19/23). "Press Release: DeuterOncology Closes €5.65M Series A Financing Round". Liège. 2023-01-19
Qiagen N.V.. (1/17/23). "Press Release: Qiagen Launches EZ2 Connect MDx Platform for Automated Sample Processing in". Venlo. 2023-01-17
BioGeneration Ventures B.V.. (1/17/23). "Press Release: BGV Appoints Jaap de Bruin as FIRST Fund Investment Manager and Promotes Rianne Ellenbroek to Principal". Amsterdam. 2023-01-17
Vésale Bioscience. (1/17/22). "Press Release: Vésale Bioscience Receives €1.8M Grant from European Innovation Council for PhageDiag Project". Namur. 2023-01-17
Qiagen N.V.. (1/9/23). "Press Release: Qiagen Completes Acquisition of Verogen, Strengthening Leadership in Human ID / Forensics with NGS Technologies". Venlo & San Diego, CA. 2023-01-09
European Invesmtent Bank (EIB). (1/9/23). "Press Release: Belgium – ExeVir Lands European Venture Debt Financing to Develop Novel Nanobody COVID-19 Therapy". 2023-01-09
1 2 3 4 5 6 7 8 9 10 11 12  next pagenext page



Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x300px

» top